In collaboration with SmartHealth Catalyzer, we cohosted a fireside chat-style talk with a startup founder and the venture capitalist who decided to invest in him.
Paul F. Burton is the managing director of 2Flo Ventures, and has become a trusted leader in Chicago's venture capital scene with over 30 years of experience in the industry.
George Pappas is the founder and CEO of Schedule 1 Therapeutics, a company developing cannabinoid medicines for FDA approval.
Venue: Sterling Bay (Lincoln Yards)